Lead Research Communicator
Malcom is a lead research communicator for Michigan Medicine and research communications strategist for the U-M Medical School, with more than 20 years of experience in strategic communications, marketing, and health and science writing. She covers the basic science departments, pulmonary and critical care medicine, infectious disease, pathology and anesthesiology. Contact: [email protected]
Health Lab
Urinary issues can be common in women, and for people with female urinary stricture, most of the treatment guidance had been based on treatments for men, until now.
Health Lab
How E coli. and other illness-causing bugs get past the microbiome’s defenses.
Health Lab
Watch four Michigan Medicine experts discuss the role of fundamental science in ending the COVID-19 pandemic.
Health Lab
A computer simulation reveals the metabolic dysfunction behind heart failure.
Health Lab
Animal model observation may reveal new cause of hypertension.
Health Lab
While there is no actual fountain of youth, a new study shows a high throughput technique could help researchers find drugs that improve health and lengthen lifespan.
Health Lab
Are the vaccine trials being rushed? Are they safe? Two Michigan Medicine researchers weigh in.
Health Lab
With raging wildfires affecting air quality, protecting your lung health is key.
Health Lab
U-M expert discusses whether repeat cases of COVID-19 is bad news for vaccines.
News Release
The University of Michigan is one of several academic medical centers partnering with the National Institutes of Health on three adaptive clinical trials to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19.
Health Lab
New research shows that targeting a protein called Nef with a molecule called concanamycin A allowed the immune system to essentially cure HIV in T cells.
Health Lab
Finding could improve outcomes for treatment of infections in people living with HIV.
News Release
Michigan Medicine is partnering with the pharmaceutical company AstraZeneca for a Phase 3 clinical trial to test a vaccine against COVID-19. The AZD1222 COVID-19 VACCINE Study will research an investigational vaccine for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2).
Health Lab
Development is first step to helping children with the rare epilepsy syndrome.
Health Lab
From flu shots to a vaccine for COVID-19, from herd immunity to vaccine safety, Dr. Pam Rockwell explains why vaccines are so important, especially during a pandemic.